Can cannabis oil stop severe itching? new trial aims to find out

NCT ID NCT06435299

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a cannabis oil containing a balanced mix of THC and CBD can safely reduce severe chronic itching. About 218 adults with severe itch (score 7 or higher on a 0-10 scale) that hasn't improved with other treatments will take either the cannabis oil or a placebo twice daily for 6 weeks. The main goal is to see if at least 30% more people in the cannabis group report a meaningful reduction in itch compared to the placebo group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cannabis oil (THC 25:CBD 25)
What this could lead to
If it works, this could offer a new treatment option for people with severe chronic itching that hasn't responded to other therapies.
What could go wrong
This is an early phase 2 trial, so it may not show a clear benefit. Side effects from THC, like dizziness or drowsiness, are possible, and the oil may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRURITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pruritus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHD Vendée

    La Roche-sur-Yon, France, 85925, France

  • CHRU de Tours

    Tours, France, 37044, France

  • CHU Angers

    Angers, France, 49000, France

  • CHU de Nantes

    Nantes, France, 44093, France

  • CHU de Poitiers

    Poitiers, France, 86000, France

  • Groupe Hospitalier La Rochelle

    La Rochelle, France, 17300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.